In a research note released yesterday, Maxim Group analyst Jason Kolbert reaffirmed a Buy rating on Synthetic Biologics (NYSE:SYN) with a $6 price target …
In a research report issued yesterday, H.C.
In a research report issued today, Brean Capital analyst Jonathan Aschoff reiterated a Buy rating on Keryx Biopharmaceuticals (NASDAQ:KERX) with a $26 price target, …
In a research note published today, Topeka Capital analyst Victor Anthony reiterated a Hold rating on eBay, Inc. (NASDAQ:EBAY) with a price target …
In a research note released Friday, Maxim Group analyst Jason Kolbert maintained a Buy rating on Keryx Biopharmaceuticals (NASDAQ: KERX) with a $24 price target, following today’s FDA approval …
In a research report published today, Roth Capital analyst Chris Lewis reiterated a Buy rating on Nanosphere (NASDAQ:NSPH) with a $1.50 price target, as NSPH …
In a research report issued today, Canaccord Genuity analyst Matthew Ramsay assigned a Hold rating on Intel (NASDAQ:INTC) with a price target of …
In a research note published today, Roth Capital analyst Debjit Chattopadhyay reiterated a Buy rating on Sarepta Therapeutics (NASDAQ:SRPT) with a $34 price target. The analyst noted, “The FDA’s …
In a research report issued today, Roth Capital analyst Debjit Chattopadhyay reiterated a Buy rating on Alcobra Ltd (NASDAQ:ADHD) with a price target …
Apple, Inc. (NASDAQ:AAPL) is a Cupertino, California based multinational corporation that designs, develops, and sells consumer electronics, computer software, and personal computers.
